STONKWHISPER
← Back to Intel
Insider ActivityETON

BRYNJELSEN SEAN, President & CEO, Director at Eton Pharmaceuticals, Inc., sold $3.8M of ETON

Updated Jun 18, 2026
BRYNJELSEN SEAN President & CEO, Director
Eton Pharmaceuticals, Inc. · $ETON
$3.8M Total Value
119,852 Shares Traded
$31.88 Price / Share
833,842 Shares Owned After
2026-05-29 Filing Date

Transaction Details

InsiderBRYNJELSEN SEAN
TitlePresident & CEO, Director
CompanyEton Pharmaceuticals, Inc.
TickerETON
Transaction TypeSale
Transaction Date2026-05-28
Shares Traded119,852
Price Per Share$31.88
Total Value$3.8M
Filed Date2026-05-29
Accession Number0001437749-26-018879

Ownership Context

Shares Owned After Transaction833,842
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001437749-26-018879

Other Insider Trades — ETON

Other Trades by BRYNJELSEN SEAN

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ETON — Eton Pharmaceuticals, Inc. →

Track ETON insider activity in real time on The Wire →

Get alerts when BRYNJELSEN SEAN files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 18, 2026 at 07:06 UTC

Want real-time data? Access The Wire for live sentiment tracking.